The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program LANCET RHEUMATOLOGY Li, J., Badve, S., Zhou, Z., Rodgers, A., Day, R., Oh, R., Lee, M., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Futcher, G., Matthews, D. R., Neal, B. 2019; 1 (4): E220–E228

View details for DOI 10.1016/S2665-9913(19)30078-5

View details for Web of Science ID 000547829100014